Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CASC | PRTA | UPB | ||
| Company | Cascadian Therapeutics Inc | Prothena Corp | Upstream Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.98 | 9.48 | 9.27 | ||
| High | 9.98 | 9.48 | 9.47 | ||
| Low | 9.98 | 9.09 | 8.70 | ||
| Latest | 9.98 | 9.31 | 9.44 | ||
| Change | -0.04 | -0.27 | +0.08 | ||
| % Change | -0.40% | -2.82% | +0.80% | ||
| Volume | 2,000 | 737,000 | 1,135,836 | ||
| 20-Day Average Volume | 587,320 | 522,030 | 2,103,497 | ||
| Previous Close | 10.02 | 9.58 | 9.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.99 | 9.21 | 8.36 | ||
| 20-Day Raw Stochastic | 28.57% | 53.73% | 28.71% | ||
| 20-Day Relative Strength | 86.57 | 50.14 | 31.79 | ||
| Weighted Alpha | +65.20 | -9.72 | +92.86 | ||
| Today's Opinion | N/A | 24% Buy | 56% Sell | ||
| Previous Opinion | N/A | 24% Buy | 56% Sell | ||
| Last Month's Opinion | N/A | 24% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.20% since 03/02/18 | -1.59% since 03/05/26 | +23.01% since 03/05/26 | ||
| Low | 9.98 on 03/09/18 | 9.09 on 03/12/26 | 7.40 on 03/06/26 | ||
| High | 10.03 on 03/08/18 | 10.27 on 03/10/26 | 9.47 on 03/12/26 | ||
| 1-Month | |||||
| %Chg | -0.10% since 02/09/18 | +5.20% since 02/12/26 | -26.29% since 02/12/26 | ||
| Low | 9.96 on 02/22/18 | 8.19 on 02/20/26 | 7.25 on 03/03/26 | ||
| High | 10.03 on 03/08/18 | 10.27 on 03/10/26 | 12.69 on 02/13/26 | ||
| 3-Month | |||||
| %Chg | +157.22% since 12/08/17 | -10.14% since 12/12/25 | -65.24% since 12/12/25 | ||
| Low | 3.52 on 01/08/18 | 8.19 on 02/20/26 | 7.25 on 03/03/26 | ||
| High | 10.21 on 01/31/18 | 10.53 on 01/23/26 | 33.68 on 01/14/26 | ||
| 6-Month | |||||
| %Chg | +177.99% since 09/08/17 | +13.40% since 09/12/25 | -46.30% since 09/12/25 | ||
| Low | 3.42 on 09/12/17 | 8.02 on 09/22/25 | 7.25 on 03/03/26 | ||
| High | 10.21 on 01/31/18 | 11.69 on 10/28/25 | 33.68 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 507,212 | 515,720 | 505,805 | ||
| Shares Outstanding, K | 50,620 | 53,833 | 54,039 | ||
| Annual Sales | 0 | 9,680,000 | 2,370,000 | ||
| Annual Net Income | -56,930,000 | -244,090,000 | -62,810,000 | ||
| Last Quarter Sales | N/A | 20,000 | 680,000 | ||
| Last Quarter Net Income | N/A | -21,590,000 | -33,750,000 | ||
| 60-Month Beta | 3.80 | -0.24 | 2.96 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 11/08/17 | -0.67 on 11/06/25 | -0.63 on 11/05/25 | ||
| Latest Earnings Date | 03/08/18 | 05/14/26 | 03/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 11/13/12 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||